Molecule Details
| InChIKey | XFYDIVBRZNQMJC-UHFFFAOYSA-N |
|---|---|
| Compound Name | Tizanidine |
| Canonical SMILES | Clc1ccc2nsnc2c1NC1=NCCN1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.38 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00697 |
|---|---|
| Drug Name | Tizanidine |
| CAS Number | 51322-75-9 |
| Groups | approved investigational |
| ATC Codes | M03BX02 |
| Description | Tizanidine is a fast-acting drug used for the management of muscle spasm, which may result from the effects of multiple sclerosis, stroke, an acquired brain injury, or a spinal cord injury [T574]. It may also be caused by musculoskeletal injury [A177583]. Regardless of the cause, muscle spasticity c... |
Categories: Adrenergic Agents Adrenergic Agonists Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Agents producing tachycardia Analgesics Anticonvulsants Autonomic Agents Bradycardia-Causing Agents Central Nervous System Agents Central Nervous System Depressants Central alpha-2 Adrenergic Agonist Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Substrates Hypotensive Agents Imidazoles Imidazolines Muscle Relaxants Muscle Relaxants, Centrally Acting Agents Musculo-Skeletal System Narrow Therapeutic Index Drugs Neuromuscular Agents Neurotransmitter Agents Potential QTc-Prolonging Agents QTc Prolonging Agents Sensory System Agents
Cross-references: BindingDB: 50240671 ChEBI: 63629 CHEMBL1079 ChemSpider: 5287 Drugs Product Database (DPD): 11821 C07452 PharmGKB: PA451701 PubChem:5487 PubChem:46505373 RxCUI: 57258 Therapeutic Targets Database: DAP000234 Wikipedia: Tizanidine ZINC: ZINC000019702309